Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marc,Ten-Blanco

第一单位： Instituto de Investigaciones Biosanitarias, Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, Spain.

作者： Marc,Ten-Blanco ^[1] ; África,Flores ^[2] ; Inmaculada,Pereda-Pérez ^[1] ; Fabiana,Piscitelli ^[3] ; Cristina,Izquierdo-Luengo ^[1] ; Luigia,Cristino ^[3] ; Julián,Romero ^[1] ; Cecilia J,Hillard ^[4] ; Rafael,Maldonado ^[2] ; Vincenzo,Di Marzo ^[5] ; Fernando,Berrendero ^[6]

作者单位： Instituto de Investigaciones Biosanitarias, Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, Spain. ^[1] Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, 08003 Barcelona, Spain. ^[2] Endocannabinoid Research Group, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Pozzuoli, Italy. ^[3] Department of Pharmacology and Toxicology and Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA. ^[4] Endocannabinoid Research Group, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Pozzuoli, Italy; Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health, Faculty of Medicine and Faculty of Agriculture and Food Sciences, Hearth and Lung Research Institute (IUCPQ), Institute of Nutrition and Functional Foods (INAF) and NUTRISS Center, Université Laval, Quebec City, Canada. ^[5] Instituto de Investigaciones Biosanitarias, Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, Spain. Electronic address: fernando.berrendero@ufv.es. ^[6]